IMCR – immunocore holdings plc - american depositary shares (US:NASDAQ)

News

VectorY Therapeutics Appoints Kevin Pojasek, Ph.D., to Board of Directors
Immunocore (NASDAQ:IMCR) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
Levicept Announces the Appointment of James Sandy as Chief Development Officer [Yahoo! Finance]
Levicept Announces the Appointment of James Sandy as Chief Development Officer
Assessing Immunocore Holdings (IMCR) Valuation After Recent Share Price Volatility [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com